What is the Impact Factor of Journal of Antibiotics?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Journal of Antibiotics is 2.70, ranking in quartile Q3 of Web of Science (SCIE).

Is Journal of Antibiotics indexed in Web of Science or Scopus?

Yes, Journal of Antibiotics is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.414 (Q3) and an H-index of 99.

Who publishes Journal of Antibiotics and what is the Article Processing Charge (APC)?

Journal of Antibiotics is published by Springer Nature. The estimated Article Processing Charge (APC) is approximately $2,923 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Journal of Antibiotics?

The official ISO-4 abbreviation of Journal of Antibiotics is "J. ANTIBIOT" with common acronym "ja". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q3SCImago #13,838Hybrid

Journal of Antibiotics

Acronym:ja

•

Abbreviation (ISO):J. ANTIBIOT

•

Identifier (ISSN):0021-8820(Print)/1881-1469(Online)

•

Publisher:Springer Nature

Official Website Submission Portal Compare

Clarivate IF (2026)

2.7– 0

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Antibiotics

WoS Q3

Annual Impact Factor Metric

Current (2026):2.7

Scopus SJR & RankScopus Q3

0.414

#13,838

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

99 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate9.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

95articles/year

11.79% Gold OA•94.12% Original Research

Aims & Scope

The Journal of Antibiotics seeks to promote research on antibiotics and related types of biologically active substances and publishes Articles, Review Articles, Brief Communication, Correspondence and other specially commissioned reports. The Journal of Antibiotics accepts papers on biochemical, chemical, microbiological and pharmacological studies. However, studies regarding human therapy do not fall under the journal’s scope. Contributions regarding recently discovered antibiotics and biologically active microbial products are particularly encouraged. Topics of particular interest within the journal's scope include, but are not limited to, those listed below: Discovery of new antibiotics and related types of biologically active substances Production, isolation, characterization, structural elucidation, chemical synthesis and derivatization, biological activities, mechanisms of action, and structure-activity relationships of antibiotics and related types of biologically active substances Biosynthesis, bioconversion, taxonomy and genetic studies on producing microorganisms, as well as improvement of production of antibiotics and related types of biologically active substances Novel physical, chemical, biochemical, microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related types of biologically active substances Newly found properties, mechanisms of action and resistance-development of antibiotics and related types of biologically active substances.

Topics Covered (Recognized by AI)

Chemistry94.9%Biology94.7%Genetics84%Biochemistry82.5%Microbiology72.3%Medicine58%Antibiotics54%Geology51.5%Paleontology51.2%Bacteria47.4%Organic chemistry45.8%Internal medicine36.4%Stereochemistry31.9%Physics25.3%Gene22.6%Pharmacology20.8%

Primary Research Areas

Rank206/356

IndexSCIE

Category	Index	Rank	Quartile
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCRSCIE	112/180	Q3
IMMUNOLOGY	JCRSCIE	124/183	Q3
MICROBIOLOGY	JCRSCIE	110/167	Q3
PHARMACOLOGY & PHARMACY	JCRSCIE	191/356	Q3
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCISCIE	105/180	Q3
IMMUNOLOGY	JCISCIE	116/183	Q3
MICROBIOLOGY	JCISCIE	107/167	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	206/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.7

Articles / Year69

Total Citations15

2025

IF2.7

Articles / Year89

Total Citations141

2024

IF2.1

Articles / Year108

Total Citations452

2023

IF3.3

Articles / Year98

Total Citations971

2022

IF3.424

Articles / Year93

Total Citations778

Year	Impact Factor	Articles / Year	Total Citations
2026	2.7	69	15
2025	2.7	89	141
2024	2.1	108	452
2023	3.3	98	971
2022	3.424	93	778
2021	2.649	102	1,374
2020	2.668	128	3,223
2019	2.446	136	2,591
2018	2.033	143	2,461
2017	—	172	4,901
2016	—	168	4,003
2015	—	139	3,116

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #13,838Scopus Q3SCImago Profile

Scopus Coverage:1953-2026

•

Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q3

0.414

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

2.46

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,923 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations676

3-Year Documents279

Citable Documents271

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ3

PharmacologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 9.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

3区BIOTECHNOLOGY & APPLIED MICROBIOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Antibiotics (acronym: ja, abbr: J. ANTIBIOT, ISSN: 0021-8820) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in Japan since 2005. The periodical holds a Journal Impact Factor (JIF) of 2.70, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.414 (Q3), an H-index of 99.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 95 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,923 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.